XERODENT

XERODENT

Marketed by: Actavis Group hf.
Active ingredient: Acidum malicum,Natrii fluoridum
Other information: lozenge - 0.25 mg / 28.6 mg

Available in: Finland
Language: English
Source: Fimea

XYLOCARD

XYLOCARD

Marketed by: Hässle Läkemedel AB
Active ingredient: Lidocaini hydrochloridum anhydricum
Other information: injection - 20 mg/ml

Available in: Finland
Language: English
Source: Fimea

XYLOCARD

XYLOCARD

Marketed by: Hässle Läkemedel AB
Active ingredient: Lidocaini hydrochloridum anhydricum
Other information: concentrate for infusion - 200 mg/ml

Available in: Finland
Language: English
Source: Fimea

XYLOPROCT

XYLOPROCT

Marketed by: AstraZeneca Oy
Active ingredient: Lidocainum,Hydrocortisoni acetas
Other information: suppository

Available in: Finland
Language: English
Source: Fimea

XYLOPROCT

XYLOPROCT

Marketed by: AstraZeneca Oy
Active ingredient: Lidocainum,Hydrocortisoni acetas
Other information: rectal ointment

Available in: Finland
Language: English
Source: Fimea

XYLOCAIN

XYLOCAIN

Marketed by: AstraZeneca Oy
Active ingredient: Lidocainum
Other information: ointment - 5 %

Available in: Finland
Language: English
Source: Fimea

XAMIOL

XAMIOL

Marketed by: Leo Pharma A/S
Active ingredient: Betamethasonum,Int-rac-alfa-Tocopheryli acetas,Calcipotriolum
Other information: gel - 50 mikrog/g + 0.5 mg/g

Available in: Finland
Language: English
Source: Fimea

XERCLEAR

XERCLEAR

Marketed by: Medivir AB
Active ingredient: Aciclovirum,Hydrocortisonum
Other information: cream - 50 mg/g + 10 mg/g

Available in: Finland
Language: English
Source: Fimea

XATRAL

XATRAL

Marketed by: sanofi-aventis Oy
Active ingredient: Alfuzosini hydrochloridum
Other information: film-coated tablet - 2.5 mg

Available in: Finland
Language: English
Source: Fimea

XATRAL

XATRAL

Marketed by: Sanofi-Synthelabo AB
Active ingredient: Alfuzosini hydrochloridum
Other information: prolonged-release tablet - 5 mg

Available in: Finland
Language: English
Source: Fimea

XATRAL CR

XATRAL CR

Marketed by: sanofi-aventis Oy
Active ingredient: Alfuzosini hydrochloridum
Other information: prolonged-release tablet - 10 mg

Available in: Finland
Language: English
Source: Fimea

XEMESTAN

XEMESTAN

Marketed by: Avansor Pharma Oy
Active ingredient: Exemestanum
Other information: film-coated tablet - 25 mg

Available in: Finland
Language: English
Source: Fimea

XEFO

XEFO

Marketed by: Nycomed Oy
Active ingredient: Lornoxicamum
Other information: tablet - 4 mg

Available in: Finland
Language: English
Source: Fimea

XEFO

XEFO

Marketed by: Nycomed Oy
Active ingredient: Lornoxicamum
Other information: tablet - 8 mg

Available in: Finland
Language: English
Source: Fimea

XEFO

XEFO

Marketed by: Nycomed Oy
Active ingredient: Lornoxicamum
Other information: powder and solvent for solution for injection - 8 mg

Available in: Finland
Language: English
Source: Fimea

XEOMIN

XEOMIN

Marketed by: Merz Pharmaceuticals GmbH
Active ingredient: Clostridium botulinum type A neurotoxin (150 kD)
Other information: powder for solution for injection - 100 LD50 yksikköä

Available in: Finland
Language: English
Source: Fimea

XEOMIN

XEOMIN

Marketed by: Merz Pharmaceuticals GmbH
Active ingredient: Clostridium botulinum type A neurotoxin (150 kD)
Other information: powder for solution for infusion - 50 LD50 yksikköä

Available in: Finland
Language: English
Source: Fimea

XYLOCAIN

XYLOCAIN

Marketed by: AstraZeneca Oy
Active ingredient: Lidocainum
Other information: nebulisation solution - 10 mg/annos

Available in: Finland
Language: English
Source: Fimea

XYLOCAIN

XYLOCAIN

Marketed by: AstraZeneca Oy
Active ingredient: Lidocaini hydrochloridum monohydricum
Other information: nasal and oromucosal solution - 40 mg/ml

Available in: Finland
Language: English
Source: Fimea

XYLOCAIN TUNG

XYLOCAIN TUNG

Marketed by: Astra Alab Ab
Active ingredient: Lidocaini hydrochloridum monohydricum
Other information: injection - 50 mg/ml

Available in: Finland
Language: English
Source: Fimea

XYLOCAIN VISKÖS

XYLOCAIN VISKÖS

Marketed by: AstraZeneca Oy
Active ingredient: Lidocaini hydrochloridum monohydricum
Other information: oral solution - 20 mg/ml

Available in: Finland
Language: English
Source: Fimea

XYLOCAIN

XYLOCAIN

Marketed by: Astra Alab Ab
Active ingredient: Lidocainum
Other information: aerosol lotion - 10 mg/annos

Available in: Finland
Language: English
Source: Fimea

XYLOCAIN

XYLOCAIN

Marketed by: AstraZeneca Oy
Active ingredient: Lidocaini hydrochloridum monohydricum
Other information: gel - 2 %

Available in: Finland
Language: English
Source: Fimea

XYLOCAIN

XYLOCAIN

Marketed by: Astra Alab Ab
Active ingredient: Lidocaini hydrochloridum monohydricum
Other information: injection - 5 mg/ml

Available in: Finland
Language: English
Source: Fimea

XYLOCAIN

XYLOCAIN

Marketed by: AstraZeneca Oy
Active ingredient: Lidocaini hydrochloridum monohydricum
Other information: solution for injection - 10 mg/ml

Available in: Finland
Language: English
Source: Fimea

XYLOCAIN

XYLOCAIN

Marketed by: AstraZeneca Oy
Active ingredient: Lidocaini hydrochloridum monohydricum
Other information: solution for injection - 20 mg/ml

Available in: Finland
Language: English
Source: Fimea

XYLOCAIN DENTAL ADRENALIN - XYLOCAIN-ADRENALIN

XYLOCAIN DENTAL ADRENALIN - XYLOCAIN-ADRENALIN

Marketed by: Dentsply Limited
Active ingredient: Lidocaini hydrochloridum monohydricum,Adrenalini hydrogenotartras
Other information: solution for injection - 20 mg/ml + 12.5 mikrog/ml

Available in: Finland
Language: English
Source: Fimea

XYLOCAIN-ADRENALIN

XYLOCAIN-ADRENALIN

Marketed by: Astra Alab Ab
Active ingredient: Adrenalini tartras,Lidocaini hydrochloridum monohydricum
Other information: injection - 5 mg/ml + 5 mikrog/ml

Available in: Finland
Language: English
Source: Fimea

XYLOCAIN-ADRENALIN

XYLOCAIN-ADRENALIN

Marketed by: AstraZeneca Oy
Active ingredient: Adrenalini tartras,Lidocaini hydrochloridum monohydricum
Other information: solution for injection - 10 mg/ml + 5 mikrog/ml

Available in: Finland
Language: English
Source: Fimea

XYLOCAIN-ADRENALIN

XYLOCAIN-ADRENALIN

Marketed by: Astra Alab Ab
Active ingredient: Adrenalini tartras,Lidocaini hydrochloridum monohydricum
Other information: injection - 20 mg/ml + 5 mikrog/ml

Available in: Finland
Language: English
Source: Fimea